Reach Out and Read (ROR) in the Neonatal Intensive Care Unit (NICU) Study
Launched by UNIVERSITY OF WASHINGTON · Aug 15, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Reach Out and Read (ROR) study is looking at how a special reading program can help families and their babies in the neonatal intensive care unit (NICU). This program aims to improve parent-child relationships, reduce anxiety for parents, and enhance literacy at home. Families will be asked to fill out three questionnaires at different times during the baby's stay in the NICU and after, to assess how reading and the ROR program affect their experiences and their baby's development.
To participate, families should have a baby born between 24 to 33 weeks of pregnancy and speak either English or Spanish. The study is currently recruiting participants and will compare those who receive the ROR program with those who get standard care. This research hopes to provide insights into how reading can support both parental well-being and the bonding experience with their infants during a challenging time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Families of subjects born between 24w0d and 33w6d gestation
- • Primary language is English or Spanish
- Exclusion Criteria:
- • Severe clinical instability such that the principal investigators do not think the infant will survive to 36 weeks gestation
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Devin McKissic
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported